According to Grips Intelligence in-store data tracked across Lowe's and Menards between January 1 and July 31, 2026, Insulfoam — a division of Carlisle Companies (NYSE: CSL) — generated 96.5% of its revenue at Lowe's, leaving just 3.5% at Menards. That concentration makes the brand's overall trajectory heavily dependent on a single retail partner. Revenue climbed 18.3% over the measured period, though the most recent month slipped 5.5% against the prior month. Average selling price reached $16.01 in the latest month, up 9.2% across the period and well above the $15.24 year-to-date average. The combination of rising prices and a recent revenue dip suggests growth has been increasingly price-led rather than volume-led.
OVER TIME
Over the last three months, revenue on tracked channels has grew by 18% from May to Jul.
OVER TIME
Over the last three months, average selling price on tracked channels has increased by 9% from May to Jul.
REVENUE SHARE
Revenue distribution across product categories for Insulfoam on Lowe's.
REVENUE SHARE
Revenue distribution across tracked channels for Insulfoam.
BY REVENUE
$149.99
Price
Revenue
$329.99
Price
Revenue
$89.99
Price
Revenue
Get access to full product performance analysis